中來股份(300393.SZ):籌劃公司控制權變更事項 國資背景投資平台將入主
格隆匯10月20日丨中來股份(300393.SZ)宣佈,公司於近日收到控股股東、實際控制人林建偉、張育政的通知,林建偉及張育政正在籌劃控制權轉讓事宜,擬將持有的部分股份轉讓給泰州姜堰道得新材料股權投資合夥企業(有限合夥),預計該次轉讓所涉及的股權比例合計不超過公司總股本的5.7%,並涉及非公開發行股票及表決權委託的相關事宜。
該事項將導致公司控股股東、實際控制人發生變更,該次交易對手方為國資背景的投資平台,該事項涉及有權部門的事前審批。公司股票自10月20日上午開市起停牌,預計停牌時間不超過5個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.